Metabolism of bilirubin by human cytochrome P450 2A6

Toxicology and Applied Pharmacology

Volumn 261, Issue 1, 2012, Pages 50-58

  Abu Bakar, A'edah ^a   Arthur, Dionne M ^a,b   Wikman, Anna S ^a,c   Rahnasto, Minna ^d   Juvonen, Risto O ^d   Vepsäläinen, Jouko ^d   Raunio, Hannu ^d   Ng, Jack C ^a,b   Lang, Matti A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Cooperative Research Centre for Contamination Assessment Remediation of the Environment ^*  (Australia)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bilirubin oxidase; Bilirubin oxidation; CYP2A6; HPLC ESI MS; Molecular docking; Oxidative stress

Indexed keywords

AMINO ACID; BILIRUBIN; BILIVERDIN; CYCLOHEXIMIDE; CYTOCHROME P450 2A6; TETRAPYRROLE DERIVATIVE;

ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; NONHUMAN; NUCLEOTIDE SEQUENCE; YEAST;

ARYL HYDROCARBON HYDROXYLASES; BILIRUBIN; BILIVERDINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXIMIDE; HALF-LIFE; HEP G2 CELLS; HUMANS; MICROSOMES; MODELS, MOLECULAR; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84860507435     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.03.010     Document Type: Article

References (45)

1. Abu-Bakar A., Satarug S., Marks G.C., Lang M.A., Moore M.R. Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2. Toxicol. Lett. 2004, 148:199-210.
2. Abu-Bakar A., Moore M.R., Lang M.A. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5. Biochem. Pharmacol. 2005, 70:1527-1535.
3. Abu-Bakar A., Lamsa V., Arpiainen S., Moore M.R., Lang M.A., Hakkola J. Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid-derived 2)-like 2. Drug Metab. Dispos. 2007, 35:787-794.
4. Abu-Bakar A., Arthur D.M., Aganovic S., Ng J.C., Lang M.A. Inducible bilirubin oxidase: a novel function for the mouse cytochrome P450 2A5. Toxicol. Appl. Pharmacol. 2011, 257:14-22.
5. Arthur, D.M., Ng, J.C., Lang, M.A., Abu-Bakar, A., in press. Urinary excretion of bilirubin oxidative metabolites in arsenite-treated mice. J. Toxicol. Sci.
6. Baranano D.E., Rao M., Ferris C.D., Snyder S.H. Biliverdin reductase: a major physiologic cytoprotectant. PNAS 2002, 99:16093-16098.
7. Cashore W.J. The neurotoxicity of bilirubin. Clin. Perinatol. 1990, 17:437-447.
8. Cohen M., Kapitulnik J., Ostrow J.D., Webster C. Effect of combined treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and phototherapy on bilirubin metabolism in the jaundiced Gunn rat. Hepatology 1986, 6:490-494.
9. Crawford J.M., Ransil B.J., Narciso J.P., Gollan J.L. Hepatic microsomal bilirubin UDP-glucuronosyltransferase: the kinetics of bilirubin mono- and diglucuronide synthesis. J. Biol. Chem. 1992, 267:16943-16950.
10. Cuypers H.T.M., Ter Haar E.M., Jansen P.L.M. Microsomal conjugation and oxidation of bilirubin. Biochim. Biophys. Acta 1983, 758:135-143.
11. De Matteis F., Dawson S.J., Boobis A.R., Comoglio A. Inducible bilirubin-degrading system of rat liver microsomes: role of cytochrome P4501A1. Mol. Pharmacol. 1991, 40:686-691.
12. De Matteis F., Dawson S.J., Gibbs A.H. Two pathways of iron-catalyzed oxidation of bilirubin: effect of desferrioxamine and trolox, and comparison with microsomal oxidation. Free Radic. Biol. Med. 1993, 15:301-309.
13. De Matteis F., Dawson S.J., Pons N., Pipino S. Bilirubin and uroporphyrinogen oxidation by induced cytochrome P4501A and cytochrome P4502B. Role of polyhalogenated biphenyls of different configuration. Biochem. Pharmacol. 2002, 63:615-624.
14. De Matteis F., Lord G.A., Lim C.K., Pons N. Bilirubin degradation by uncoupled cytochrome P450. Comparison with a chemical oxidation system and characterization of the products by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:1209-1217.
15. Dore S., Takahashi M., Ferris C.D., Hester L.D., Guastella D., Snyder S.H. Bilirubin, formed by activation of haem oxygenase-2, protects neurons against oxidative stress injury. PNAS 1999, 96:2445-2450.
16. Draper A.J., Madan A., Parkinson A. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys. 1997, 341:47-61.
17. Fletcher A.A. New approach to variable metric algorithms. Comput. J. 1970, 13:317-322.
18. Geneste O., Raffalli F., Lang M.A. Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2A5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization. Biochem. J. 1996, 313:1029-1037.
19. Guengerich F.P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 2001, 14:611-650.
20. Halgren T. Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comput. Chem. 1996, 17:520-552.
21. Jansen T., Hortmann M., Oleze M., Opitz B., Steven S., Schell R., Knorr M., Karbach S., Schuhmacher S., Wenzel P., Münzel T., Daiber A. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J. Mol. Cell. Cardiol. 2010, 49:186-195.
22. Jin M., Arya P., Patel K., Singh B., Silverstein P.S., Bhat H.K., Kumar A., Kumar S. Effect of alcohol on drug efflux protein and drug metabolic enzyme in U937 macrophages. Alcohol. Clin. Exp. Res. 2011, 35:132-139.
23. Jones G., Willett P., Glen R.C., Leach A.R., Taylor R. Development and validation of a genetic algorithm for flexible ligand docking. Abstr. Pap. Am. Chem. Soc. 1997, 214. (154-COMP).
24. Juvonen R., Kaipainen P., Lang M.A. Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. Eur. J. Biochem. 1985, 152:3-8.
25. Kapitulnik J., Ostrow J.D. Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases. PNAS 1978, 75:682-685.
26. Keshavan P., Schwemberger S.J., Smith D.L., Babcock G.F., Zucker S.D. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int. J. Cancer 2004, 112:433-445.
27. Kinonen T., Pasanen M., Gynther J., Poso A., Jarvinen T., Alhava E., Juvonen R.O. Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP2As and human CYP2A6. Br. J. Pharmacol. 1995, 116:2625-2630.
28. Lindahl E., Hess B., van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Model. 2001, 7:306-317.
29. Menken M., Waggoner J.G., Berlin N.I. The influence of bilirubin in oxidative phosphorylation and related reactions in brain and liver mitochondria: effects of protein-binding. J. Neurochem. 1966, 13:1241-1248.
30. Niemela O., Parkkila S., Juvenon R.O., Viitala K., Gelbion H.V., Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J. Hepatol. 2000, 33:893-901.
31. Noir B.A., Boveris A., Garaza Pereira A.M., Stoppani A.O. Bilirubin: a multi-site inhibitor of mitochondrial respiration. FEBS Lett. 1972, 27:270-274.
32. Pons N., Pipino S., De Matteis F. Interaction of polyhalogenated compounds of appropriate configuration with mammalian or bacterial CYP enzymes increased bilirubin and uroporphyrinogen oxidation in vitro. Biochem. Pharmacol. 2003, 66:405-414.
33. Rahnasto M., Wittekindt C., Juvonen R.O., Turpeinen M., Petsalo A., Pelkonen O., Poso A., Stahl G., Höltje H.D., Raunio H. Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme - an in silico approach. Pharmacogenomics J. 2008, 8:328-338.
34. Raunio H., Juvenon R., Pasanen M., Pelkonen O., Paakko P., Soini Y. Cytochrome P4502A6 (CYP2A6) expression in human hepatocellular carcinoma. Hepatology 1998, 27:427-432.
35. Reed G.A., Lasker J.M., Eling T.E., Sivarajah K. Peroxidative oxidation of bilirubin during prostaglandin biosynthesis. Prostaglandins 1985, 30:153-165.
36. 14C-bilirubin in congenital non-hemolytic jaundice. J. Clin. Invest. 1963, 42:1720-1734.
37. Sedlak T.W., Snyder S.H. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004, 113:1776-1782.
38. Stahl G.R., Höltje H.D. Development of models for cytochrome P450 2A5 as well as two of its mutants. Pharmazie 2005, 60:247-253.
39. Stocker R. Antioxidant activities of bile pigments. Antioxid. Redox Signal. 2004, 6:841-849.
40. Stocker R., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. PNAS 1987, 84:8130-8134.
41. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40:581-616.
42. Verdonk M.L., Cole J.C., Hartshorn M.J., Murray C.W., Taylor R.D. Improved protein-ligand docking using GOLD. Proteins 2003, 52:609-623.
43. Yabusaki Y. Expression of mammalian cytochromes P450 in yeast. Cytochrome P450 Protocols 1998, 195-202. Humana Press, New Jersey. I.R. Phillips, E.A. Shephard (Eds.).
44. Yano J.K., Denton T.T., Cerny M.A., Zhang X., Johnson E.F., Cashman J.R. Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein co-crystallization. J. Med. Chem. 2006, 49:6987-7001.
45. Yokota S., Higashi E., Fukami T., Yokoi T., Nakajima M. Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2. Biochem. Pharmacol. 2011, 81:289-294.